How do the WARMTH and Vision trials differ?
- Forums
- ASX - By Stock
- NOX
- Ann: New Independent Trial Data Supports Potential of Veyonda
NOX
noxopharm limited
Add to My Watchlist
0.00%
!
5.1¢

Ann: New Independent Trial Data Supports Potential of Veyonda, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
5.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.90M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 763 | 5.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.1¢ | 107266 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 763 | 0.050 |
1 | 300000 | 0.048 |
2 | 114034 | 0.047 |
1 | 50000 | 0.046 |
4 | 252666 | 0.045 |
Price($) | Vol. | No. |
---|---|---|
0.051 | 107266 | 2 |
0.052 | 78600 | 1 |
0.055 | 60000 | 1 |
0.056 | 20000 | 1 |
0.057 | 10730 | 1 |
Last trade - 09.59am 08/07/2025 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |
Day chart unavailable
The Watchlist
AGC
AUSTRALIAN GOLD AND COPPER LTD
Glen Diemar, MD
Glen Diemar
MD
SPONSORED BY The Market Online